← Back to Clinical Trials
Recruiting NCT06900452

NCT06900452 The Effect of Pistachio-Rich Breakfast Meals on Cognitive Function in Healthy Older Adults

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06900452
Status Recruiting
Phase
Sponsor University of Reading
Condition Cognition
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2025-03-06
Primary Completion 2025-11

Eligibility & Interventions

Sex All sexes
Min Age 65 Years
Max Age 80 Years
Study Type INTERVENTIONAL
Interventions
0.5 serving of pistachios1 serving of pistachios2 servings of pistachios

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 52 participants in total. It began in 2025-03-06 with a primary completion date of 2025-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to investigate the effect of a breakfast meal containing varying serving sizes (doses) of pistachio nuts on cognitive function throughout the course of the day in healthy ageing adults aged 65-80.

Eligibility Criteria

Inclusion Criteria: * 65 - 80 years old * Fruit \& veg intake less than or equal to 4 servings per day * Not regularly consuming more than 3 servings of fish per week * Adequate English language and visual \& auditory acuity to perform the cognitive tasks * Normal BMI for age * Normal MMSE performance between 26-30 Exclusion Criteria: * Being diagnosed with psychological or psychiatric disorders * ADHD or dyslexia * Any food allergy or intolerance * Use of medications and dietary supplements that may impact study results * Antibiotic use within the last 3 months * Adherence to vegan or vegetarian diets, or other specific diets that may impact study outcomes * Being diagnosed with cardiometabolic disease (including type II diabetes and cardiovascular disease), or suffer from untreated hypertension or thrombosis related disorders * Taking blood thinners

Contact & Investigator

Central Contact

Claire Williams, PhD

✉ claire.williams@reading.ac.uk

📞 0118 378 7540

Principal Investigator

Claire Williams, PhD

PRINCIPAL INVESTIGATOR

University of Reading

Frequently Asked Questions

Who can join the NCT06900452 clinical trial?

This trial is open to participants of all sexes, aged 65 Years or older, up to 80 Years, studying Cognition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06900452 currently recruiting?

Yes, NCT06900452 is actively recruiting participants. Contact the research team at claire.williams@reading.ac.uk for enrollment information.

Where is the NCT06900452 trial being conducted?

This trial is being conducted at Reading, United Kingdom.

Who is sponsoring the NCT06900452 clinical trial?

NCT06900452 is sponsored by University of Reading. The principal investigator is Claire Williams, PhD at University of Reading. The trial plans to enroll 52 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology